U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female rats

Journal of Perinatology

Volumn 35, Issue 3, 2015, Pages 454-460

  Ahnstedt, Hilda ^a   Mostajeran, Maryam ^a   Blixt, Frank W ^a   Warfvinge, Karin ^a   Ansar, Saema ^a   Krause, Diana N ^b   Edvinsson, Lars ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cerebral ischemia; endothelin receptors; extracellular signal regulated kinase 1 and 2; female; middle cerebral artery occlusion; U0126

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; 1,3 BUTADIENE DERIVATIVE; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENZYME INHIBITOR; NEUROPROTECTIVE AGENT; NITRILE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; BRAIN ARTERY; BRAIN INFARCTION SIZE; CONTROLLED STUDY; ENZYME ACTIVATION; EXPERIMENTAL STROKE; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; MYOGRAPHY; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REPERFUSION; TREATMENT OUTCOME; ANIMAL; BRAIN CIRCULATION; CEREBROVASCULAR ACCIDENT; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASOCONSTRICTION; WISTAR RAT;

ANIMALS; BUTADIENES; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; IMMUNOHISTOCHEMISTRY; MAP KINASE SIGNALING SYSTEM; NEUROPROTECTIVE AGENTS; NITRILES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECOVERY OF FUNCTION; STROKE; VASOCONSTRICTION;

EID: 84938527442     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.217     Document Type: Article

References (31)

1. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009; 40: 1082-1090.
2. Turtzo LC, McCullough LD. Sex-specific responses to stroke. Future Neurol 2010; 5: 47-59.
3. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke 2005; 36: 62-65.
4. Saposnik G, Di Legge S, Webster F, Hachinski V. Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 2005; 65: 1169-1174.
5. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE et al. A randomized trial of low-Dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352: 1293-1304.
6. SCotPHSR G. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989; 321: 129-135.
7. Vikman P, Edvinsson L. Gene expression profiling in the human middle cerebral artery after cerebral ischemia. Eur J Neurol 2006; 13: 1324-1332.
8. Hansen-Schwartz J, Hoel NL, Zhou M, Xu CB, Svendgaard NA, Edvinsson L. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 2003; 52: 1188-1194, 1194-1185
9. Stenman E, Malmsjo M, Uddman E, Gido G, Wieloch T, Edvinsson L. Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke 2002; 33: 2311-2316.
10. Edvinsson LI, Povlsen GK. Vascular plasticity in cerebrovascular disorders. J Cereb Blood Flow Metab 2011; 31: 1554-1571.
11. Povlsen GK, Waldsee R, Ahnstedt H, Kristiansen KA, Johansen FF, Edvinsson L. In vivo experimental stroke and in vitro organ culture induce similar changes in vasoconstrictor receptors and intracellular calcium handling in rat cerebral arteries. Exp Brain Res 2012; 219: 507-520.
12. Henriksson M, Stenman E, Vikman P, Edvinsson L. MEK1/2 inhibition attenuates vascular ETA and ETB receptor alterations after cerebral ischaemia. Exp Brain Res 2007; 178: 470-476.
13. Maddahi A, Edvinsson L. Enhanced expressions of microvascular smooth muscle receptors after focal cerebral ischemia occur via the MAPK MEK/ERK pathway. BMC Neurosci 2008; 9: 85.
14. Goldman JM, Murr AS, Cooper RL. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol 2007; 80: 84-97.
15. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986; 17: 472-476.
16. Engelhorn T, Goerike S, Doerfler A, Okorn C, Forsting M, Heusch G et al. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 2004; 24: 467-474.
17. Encarnacion A, Horie N, Keren-Gill H, Bliss TM, Steinberg GK, Shamloo M. Longterm behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods 2011; 196: 247-257.
18. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990; 10: 290-293.
19. Ahnstedt H, Cao L, Krause DN, Warfvinge K, Saveland H, Nilsson OG et al. Malefemale differences in upregulation of vasoconstrictor responses in human cerebral arteries. PLoS ONE 2013; 8: e62698.
20. Ahnstedt H, Saveland H, Nilsson O, Edvinsson L. Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK-sensitive signaling pathway. BMC Neurosci 2011; 12: 5.
21. Khalil RA. Modulators of the vascular endothelin receptor in blood pressure regulation and hypertension. Curr Mol Pharmacol 2011; 4: 176-186.
22. Sharifi AM, Schiffrin EL. Endothelin receptors mediating vasoconstriction in rat pressurized small arteries. Can J Physiol Pharmacol 1996; 74: 934-939.
23. McCulloch KM, MacLean MR. EndothelinB receptor-mediated contraction of human and rat pulmonary resistance arteries and the effect of pulmonary hypertension on endothelin responses in the rat. J Cardiovasc Pharmacol 1995; 26: S169-S176.
24. Henriksson M, Stenman E, Vikman P, Edvinsson L. Protein kinase C inhibition attenuates vascular ETB receptor upregulation and decreases brain damage after cerebral ischemia in rat. BMC Neurosci 2007; 8: 7.
25. Tostes Passaglia RC, David FL, Fortes ZB, Nigro D, Scivoletto R, Catelli De Carvalho MH. Deoxycorticosterone acetate-salt hypertensive rats display gender-related differences in ET(B) receptor-mediated vascular responses. Br J Pharmacol 2000; 130: 1092-1098.
26. Sawe N, Steinberg G, Zhao H. Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res 2008; 86: 1659-1669.
27. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke 1998; 29: 159-165, discussion 166.
28. Lopez-Valdes HE, Clarkson AN, Ao Y, Charles AC, Carmichael ST, Sofroniew MV et al. Memantine enhances recovery from stroke. Stroke 2014; 45: 2093-2100.
29. Geary GG, Krause DN, Duckles SP. Estrogen reduces myogenic tone through a nitric oxide-Dependent mechanism in rat cerebral arteries. Am J Physiol 1998; 275: H292-H300.
30. Ospina JA, Duckles SP, Krause DN. 17beta-estradiol decreases vascular tone in cerebral arteries by shifting COX-Dependent vasoconstriction to vasodilation. Am J Physiol Heart Circ Physiol 2003; 285: H241-H250.
31. Ospina JA, Krause DN, Duckles SP. 17beta-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke 2002; 33: 600-605.